Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.45 |
| ▸ | PRKCA | P17252 | 4/20 | 0.45 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | FASN | P49327 | 1/20 | 0.42 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.41 |
| ▸ | PRKCG | P05129 | 1/20 | 0.41 |
| ▸ | PRKCB | P05771 | 1/20 | 0.41 |
| ▸ | PRKCH | P24723 | 1/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.41 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.41 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.41 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3887138 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15656548 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15657689 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL14718758 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15655302 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15659839 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15658403 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15660716 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL4653719 | 1.00 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL3923431 | 0.98 | CYP1A2 (0.48) | CYP1A2CES2ABHD16APRKCADAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1412309-B1 | EPOXIDE STABILIZATION OF FLUOROPHOSPHITE-METAL CATALYST SYSTEM | EASTMAN CHEM CO (US) | 2015-04-29 | — | — | EP | claimed |
| EP-1412309-A2 | EPOXIDE STABILIZATION OF FLUOROPHOSPHITE-METAL CATALYST SYSTEM | EASTMAN CHEMICAL COMPANY (US) | 2004-04-28 | — | — | EP | claimed |
| US-6693219-B2 | PREVENTING FLUOROPHOSPHITE LIGANDS HYDROLYSIS BY ADDING AN EPOXIDE; CATALYTIC HYDROFORMYLATION OF ALPHA-OLEFIN, HYDROGEN, CARBON MONOXIDE FOR PRODUCING ALDEHYDES | EASTMAN CHEMICAL COMPANY | 2004-02-17 | — | — | US | claimed |
| US-20030018220-A1 | Preventing fluorophosphite ligands hydrolysis by adding an epoxide; catalytic hydroformylation of alpha-olefin, hydrogen, carbon monoxide for producing aldehydes | EASTMAN CHEMICAL COMPANY | 2003-01-23 | — | — | US | claimed |
| WO-2002098825-A2 | EPOXIDE STABILIZATION OF FLUOROPHOSPHITE-METAL CATALYST SYSTEM | EASTMAN CHEMICAL COMPANY (US) | 2002-12-12 | — | — | WO | claimed |
| EP-2735581-B1 | COMPOSITION AND POLYMER | ASAHI CHEMICAL IND (JP) | 2021-07-14 | — | — | EP | disclosed |
| US-9738757-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160222168-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-08-04 | — | — | US | disclosed |
| US-9334371-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-05-10 | — | — | US | disclosed |
| EP-2735581-A1 | COMPOSITION AND POLYMER | Asahi Kasei Chemicals Corporation (JP) | 2014-05-28 | — | — | EP | disclosed |
| US-20140121293-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| US-6740317-B1 | AQUEOUS HAIR CARE COMPOSITION COMPRISING MACROCYCLIC LACTONE AND EICOSANOATE ESTER | MELALEUCA, INC. | 2004-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030018220-A1 | Preventing fluorophosphite ligands hydrolysis by adding an epoxide; catalytic hydroformylation of alpha-olefin, hydrogen, carbon monoxide for producing aldehydes | CYP2F1, CYP4F2, CYP4F11 | CYP1A2 76/4885CES2 883/4885ABHD16A 3714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.